Assess the Downregulation of HIV-1 When Raltegravir is Added to a Virologically Suppressed HAART Regimen
This study has been completed.
Sponsor:
National Jewish Health
Collaborator:
Merck
Information provided by:
National Jewish Health
ClinicalTrials.gov Identifier:
NCT00738569
First received: August 19, 2008
Last updated: March 10, 2011
Last verified: March 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | February 2011 |
| Primary Completion Date: | February 2011 (Final data collection date for primary outcome measure) |